Micromet's IPO

Micromet raised a round of funding on August 17, 2007. Investors include Public.

Micromet is focused on biological products for the treatment and control of cancer, inflammatory and autoimmune diseases. Using its antibody technology platforms, Micromet strives to create novel drug…

Articles about Micromet's IPO: